Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo

Molecular Therapy — Nucleic Acids(2020)10.1016/j.omtn.2020.01.018Source: DataRank Database

Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo is a research paper published in Molecular Therapy — Nucleic Acids (2020). On theSindex it has a DataRank of 0. It has been cited 100 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access100 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.88)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Feihe Ma ORCID,Fang Liu ORCID,Jinjin Chen ORCID,Xuewei Zhao ORCID,Qiaobing Xu ORCID

Live enrichment

PubMed:32160706 PMC:PMC7036716 OpenAlex:https://openalex.org/W3002543944

National Institutes of Health

Grant: R01 EB027170-01

National Institutes of Health

Grant: 1R21EB024041-01

Engineer synthetic exosome for promoting axon growth

NIBIB NIH HHS

Grant: R01 EB027170

NIBIB NIH HHS

Grant: R21 EB024041

National Institutes of Health

Grant: 1R01EB027170-01

ROS-responsive Chemical Modification of Protein and Its Delivery

FWCI

3.88

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.omtn.2020.01.018

GOLDhttps://doi.org/10.1016/j.omtn.2020.01.018

publisherhttps://doi.org/10.1016/j.omtn.2020.01.018

publisherhttps://api.elsevier.com/content/article/PII:S2162253120300536?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2162253120300536?httpAccept=text/plain

Fields of Study

RNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesDNA and Nucleic Acid ChemistryMedicineChemistryBiology0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

KexinIn vivoProprotein convertasePCSK9In vitroSolid lipid nanoparticleChemistryHEK 293 cellsOligonucleotideSubtilisinPharmacologyDrug deliveryBiologyCholesterolBiochemistryLDL receptorLipoproteinBiotechnologyReceptorGeneEnzymeAntisense oligonucleotideBiodegradable Lipid NanoparticleTherapeutics. PharmacologyRM1-950Article